Bribery Act 2010

Bribery Act 2010
Sodacan · CC BY-SA 3.0 · source
Title	Bribery Act 2010
Long title	An Act to make provision about offences relating to bribery
Enacted by	Parliament of the United Kingdom
Royal assent	8 April 2010
Commencement	1 July 2011
Status	Current

Bribery Act 2010 The Bribery Act 2010 is United Kingdom legislation reforming bribery law and introducing new corporate liability for failing to prevent bribery, enacted by the Parliament of the United Kingdom and receiving royal assent from Elizabeth II. The statute replaced and supplemented provisions from the Prevention of Corruption Act 1906, reshaping relations with international instruments such as the United Nations Convention against Corruption and the Organisation for Economic Co-operation and Development OECD Anti-Bribery Convention. The Act has influenced compliance practice across firms headquartered in jurisdictions such as London, New York City, Brussels, Hong Kong, and Singapore.

Background and enactment

The Act originated from recommendations by the Law Commission (England and Wales) and the Scottish Law Commission in reports citing comparative models like the United States Foreign Corrupt Practices Act and the Canadian Corruption of Foreign Public Officials Act. Debates in the House of Commons and the House of Lords invoked precedents from cases involving institutions such as Barclays, Siemens, GlaxoSmithKline, VimpelCom, and Rolls-Royce Holdings plc. International pressure from the G20 and scrutiny by the European Commission and Transparency International shaped parliamentary amendments before the Act’s passage under a Conservative–Liberal Democrat coalition administration.

Key provisions

The Act creates offences of active and passive bribery, and distinct offences relating to bribery of foreign public officials, drawing on terminology used by the World Bank and the International Monetary Fund. It defines "improper performance" in ways referenced by adjudicators in forums like the Crown Court and collegial tribunals such as the International Criminal Court. The Act introduces a corporate offence of failing to prevent bribery, which has been compared with provisions in the Sarbanes–Oxley Act and standards promoted by ISO guidance. Provisions allow for deferred prosecution agreements administered by the Serious Fraud Office and influenced by practice in jurisdictions including United States Department of Justice and UK DOJ-equivalent frameworks.

Corporate liability and offences

Corporate liability under the Act attaches to legal persons including companies listed on the London Stock Exchange, subsidiaries of multinationals such as BP, Royal Dutch Shell, HSBC, and state-owned enterprises engaged in transactions in markets like India, Nigeria, China, and Brazil. The "failure to prevent" offence obliges boards of directors drawn from firms similar to Unilever and AstraZeneca to implement proportionate procedures aligned with guidance from bodies like the Ministry of Justice (United Kingdom) and professional associations including the Institute of Chartered Accountants in England and Wales and the Bar Council. Liability can arise even where bribery was perpetrated overseas by agents or intermediaries connected to enterprises active in financial centers such as Zurich and Geneva.

Enforcement and penalties

Enforcement is carried out primarily by the Serious Fraud Office and the Crown Prosecution Service, supported by regulatory agencies like Her Majesty's Revenue and Customs and international cooperation with authorities such as the Federal Bureau of Investigation, European Public Prosecutor's Office, and prosecutors in Germany and France. Sanctions under the Act include unlimited financial penalties, confiscation orders in proceedings akin to those in the Proceeds of Crime Act 2002, and ancillary measures like debarment from procurements by bodies including the United Nations and the World Bank. Enforcement outcomes sometimes involve negotiated resolutions analogous to deferred prosecution agreements used in high-profile settlements with corporations like Siemens AG and GlaxoSmithKline plc.

Impact and compliance guidance

The Act prompted extensive guidance from the Ministry of Justice (United Kingdom), the FCPA Pilot Program, the Institute of Directors, and Transparency International UK, shaping compliance regimes within professional services firms such as PricewaterhouseCoopers, Deloitte, Ernst & Young, and KPMG. Multinational enterprises with operations in jurisdictions like Russia, Mexico, and South Africa adopted enhanced internal controls, third-party due diligence, and board-level reporting consistent with recommendations from the Financial Conduct Authority and international standards such as ISO 37001. Academic commentary in journals published by Oxford University Press, Cambridge University Press, and legal analyses from chambers like Brick Court Chambers have debated the Act’s extraterritorial reach and effects on mergers and acquisitions reviewed by the Competition and Markets Authority.

Notable cases and prosecutions

Notable matters invoking the Act include investigations and resolutions involving defendants and corporations frequently named in global enforcement discourse, with cases coordinated among agencies like the Serious Fraud Office, the US Department of Justice, and prosecutors in Netherlands and Italy. High-profile inquiries referencing practices in sectors dominated by firms such as Rolls-Royce, Glencore, Unaoil, and Sandline International have tested evidentiary thresholds in the Crown Court and appellate decisions considered by judicial review panels in the Royal Courts of Justice. Outcomes have informed guidance issued by the Ministry of Justice (United Kingdom) and have been cited in comparative law studies at institutions like Harvard Law School and University of Cambridge.

Category:United Kingdom legislation Category:Anti-corruption law